Andreas Dietz

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

S. Staar, Volker Rudat, Hartmut Stuetzer et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 359 citations

Medicine, Oncology, Radiation Oncology +13

Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.

Thomas Andl, Tomas Kahn, Andreas Pfuhl et al. · PubMed · 1998 · 283 citations

Medicine, Genetics, Oncology +17

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Heide Götze, Michael Friedrich, Sabine Taubenheim et al. · Supportive Care in Cancer · 2019 · 280 citations

Nursing, Oncology, Psychiatry +12

The role of HPV RNA transcription, immune response‐related gene expression and disruptive<i>TP53</i>mutations in diagnostic and prognostic profiling of head and neck cancer

Gunnar Wichmann, Maciej Rosołowski, Knut Krohn et al. · International Journal of Cancer · 2015 · 278 citations · Full text

Medicine, Molecular Biology, Oncology +17